Jacobs Levy Equity Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Jacobs Levy Equity Management’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,129	Closed	-$361K	–	1112
2021 Q3	$361K	Sell	22,129 -8,927	-29%	-$160K	﹤0.01%	912
2021 Q2	$575K	Sell	31,056 -84,803	-73%	-$1.63M	﹤0.01%	840
2021 Q1	$1.75M	Buy	115,859 +93,730	+424%	+$2.04M	0.01%	628
2020 Q4	$715K	Buy	+22,129	New	+$293K	0.01%	796

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management's CDAK Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q4 2021, closing a stake of 22,129 shares — an estimated $361K sold.

Jacobs Levy Equity Management first reported a position in CDAK in Q4 2020 and held it in 4 quarters. The position peaked at $1.75M in Q1 2021. 51 funds tracked by Wall St. Rank hold CDAK as of Q4 2021.

Jacobs Levy Equity Management reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 22,129 Codiak BioSciences, Inc. Common Stock shares in Q4 2021, an estimated $361K.
Jacobs Levy Equity Management first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Jacobs Levy Equity Management's Codiak BioSciences, Inc. Common Stock position peaked at $1.75M in Q1 2021.
51 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.